These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4308291)

  • 21. [Viomycin in experimental diphtheria infections].
    MASI A; DETTORI M
    Riv Clin Pediatr; 1952 Aug; 50(8):559-62. PubMed ID: 13004796
    [No Abstract]   [Full Text] [Related]  

  • 22. Mode of action of viomycin on Rhizobium meliloti.
    Jordan DC; Yamamura Y; McKague ME
    Can J Microbiol; 1969 Sep; 15(9):1005-12. PubMed ID: 4313425
    [No Abstract]   [Full Text] [Related]  

  • 23. Electrolyte changes due to viomycin.
    CLARKE M; McCARTHY CF
    Tubercle; 1961 Sep; 42():358-61. PubMed ID: 13693897
    [No Abstract]   [Full Text] [Related]  

  • 24. [Some chemotherapeutic agents used infrequently in the treatment of human pulmonary tuberculosis: viomycin, oxytetracycline, neomycin, framycetin].
    SEREMBE M
    Clin Ter; 1958 Apr; 14(4):393-431. PubMed ID: 13547447
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antitubercular properties of isoxyl (4,4-di-isoamyl-oxycarbanilid)].
    Janowiec M
    Gruzlica; 1969 May; 37(5):417-23. PubMed ID: 4979708
    [No Abstract]   [Full Text] [Related]  

  • 26. The pantothenates of streptomycin, viomycin, and neomycin, new and less toxic salts.
    KELLER H; KRUPE W; MUCKTER H; SOUS H
    Antibiot Annu; 1955-1956; 3():35-8. PubMed ID: 13355243
    [No Abstract]   [Full Text] [Related]  

  • 27. The antibiotic viomycin traps the ribosome in an intermediate state of translocation.
    Ermolenko DN; Spiegel PC; Majumdar ZK; Hickerson RP; Clegg RM; Noller HF
    Nat Struct Mol Biol; 2007 Jun; 14(6):493-7. PubMed ID: 17515906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [On the susceptibility of Bacillus anthracis and Erysipelothrix rhusiopathiae to viomycin in vitro and in vivo].
    Deom J; Mortelmans J
    Rev Immunol Ther Antimicrob; 1955; 19(4):346-51. PubMed ID: 13311088
    [No Abstract]   [Full Text] [Related]  

  • 29. [Histological modifications of the endocrine glands in experimental animals treated with viomycin].
    BESTA B; DE SIMONI G
    Lotta Tuberc; 1955 Sep; 25(9):525-8. PubMed ID: 13296393
    [No Abstract]   [Full Text] [Related]  

  • 30. [Various biological tests on several groups of subjects with tuberculosis subjected respectively to monotherapy with isoniazid, viomycin, pyrazinamide, cycloserine, ethioniamide and kanamycin].
    DE SIMONI G; CATTANEO C
    Ann Ist Carlo Forlanini; 1962; 22():326-65. PubMed ID: 14026068
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal function during viomycin administration to dogs.
    MOYER JH; HANDLEY CA
    Proc Soc Exp Biol Med; 1953 Apr; 82(4):761-3. PubMed ID: 13055992
    [No Abstract]   [Full Text] [Related]  

  • 32. Further investigations with a view to enhancing the tolerance of streptomycin, viomycin, and neomycin by means of pantothenic acid.
    KELLER H; KRUPE W; SOUS H; MUCKTER H
    Antibiot Annu; 1956-1957; ():549-53. PubMed ID: 13425431
    [No Abstract]   [Full Text] [Related]  

  • 33. [Histological changes of the endocrine glands in experimental animals treated with viomycin. II. Hypophysis].
    BESTA B; DE SIMONI G
    Lotta Tuberc; 1955 Dec; 25(12):853-6. PubMed ID: 13321007
    [No Abstract]   [Full Text] [Related]  

  • 34. [Histological changes of the endocrine glands in experimental animals treated with viomycin. III. Adrenals].
    BESTA B; DE SIMONI G
    Lotta Tuberc; 1955 Dec; 25(12):857-64. PubMed ID: 13321008
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of an intermittent dosage schedule of viomycin on renal function and on plasma electrolytes.
    MOYER JH; JONES PO; FORD RV; JENKINS DE; MILLS LC
    Am Rev Tuberc; 1953 Oct; 68(4):541-7. PubMed ID: 13104866
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of viomycin on the labyrinthine, sensory and retinal chronaxy in subjects with lung tuberculosis].
    Fafrowicz B; Kamyszew A
    Ann Acad Med Stetin; 1970; 16():417-24. PubMed ID: 4339298
    [No Abstract]   [Full Text] [Related]  

  • 37. [Study of the antitubercular activity of new derivatives of aromatic hydrazides. IX. Antitubercular activity in vitro of several new substituted isonicotinoylhydrazides, diphenylsulfonylhydrazides and diphenylsulfonylhydrazidones].
    Teitel A; Stroescu V; Demetrescu C; Beneş H; Chiriţă C; Gane P; Steflea D; Chiculescu O
    Fiziol Norm Patol; 1967; 13(6):551-60. PubMed ID: 4969837
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cross resistance of Mycobacterium tuberculosis to streptomycin, kanamycin and viomycin].
    Makarevich NM; Mkrtchian SV; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):345-51. PubMed ID: 4321321
    [No Abstract]   [Full Text] [Related]  

  • 39. NEW approved drugs.
    Med Bull (Ann Arbor); 1951 Jan; 17(1):24-8. PubMed ID: 14809849
    [No Abstract]   [Full Text] [Related]  

  • 40. [Significance of isoniazid for the therapy of experimental infection with total INH- and SM- resistant human tuberculosis bacteria in the mice].
    Matsumiya T; Freerksen E; Rosenfeld M
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):14-29. PubMed ID: 4320557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.